Home > Publications Database > Myocardial injury in transient global amnesia: a case-control study. > print |
001 | 140772 | ||
005 | 20240321220854.0 | ||
024 | 7 | _ | |a 10.1111/ene.13920 |2 doi |
024 | 7 | _ | |a pmid:30706590 |2 pmid |
024 | 7 | _ | |a 1351-5101 |2 ISSN |
024 | 7 | _ | |a 1468-1331 |2 ISSN |
024 | 7 | _ | |a 1471-0552 |2 ISSN |
024 | 7 | _ | |a altmetric:54900454 |2 altmetric |
037 | _ | _ | |a DZNE-2020-07094 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Erdur, H. |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
245 | _ | _ | |a Myocardial injury in transient global amnesia: a case-control study. |
260 | _ | _ | |a Oxford |c 2019 |b Blackwell Science78889 |
264 | _ | 1 | |3 online |2 Crossref |b Wiley |c 2019-02-21 |
264 | _ | 1 | |3 print |2 Crossref |b Wiley |c 2019-07-01 |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1592492814_24922 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Elevation of cardiac troponin (cTn), a sensitive biomarker of myocardial injury, is frequently observed in severe acute neurological disorders. Case reports suggest that cardiac dysfunction may also occur in patients with transient global amnesia (TGA). Until now, no study has systematically assessed this phenomenon.We performed a case-control study using data of consecutive patients presenting with TGA from 2010 to 2015. Multiple logistic regression analysis accounting for age, sex and cardiovascular risk factors was performed to compare the likelihood of myocardial injury [defined as elevation of cTn > 99th percentile (≥14 ng/L); highly sensitive cardiac troponin T assay] in TGA with three reference groups: migraine with aura, vestibular neuritis and transient ischaemic attack (TIA).Cardiac troponin elevation occurred in 28 (25%) of 113 patients with TGA. Patients with TGA with cTn elevation were significantly older, more likely to be female and had higher blood pressure on admission compared with those without. The likelihood of myocardial injury following TGA was at least more than twofold higher compared with all three reference groups [adjusted odds ratio, 5.5; 95% confidence interval (CI), 1.2-26.4, compared with migraine with aura; adjusted odds ratio, 2.2; 95% CI, 1.2-4.4, compared with vestibular neuritis; adjusted odds ratio, 2.3; 95% CI, 1.3-4.2, compared with TIA].One out of four patients with TGA had evidence of myocardial injury as assessed by highly sensitive cTn assays. The likelihood of myocardial injury associated with TGA was even higher than in TIA patients with a more pronounced cardiovascular risk profile. Our findings suggest the presence of a TGA-related disturbance of brain-heart interaction that deserves further investigation. |
536 | _ | _ | |a 899H - Addenda (POF3-899H) |0 G:(DE-HGF)POF3-899H |c POF3-899H |f POF III |x 0 |
542 | _ | _ | |i 2019-02-21 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
542 | _ | _ | |i 2019-02-21 |2 Crossref |u http://onlinelibrary.wiley.com/termsAndConditions#vor |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
650 | _ | 2 | |a Aged |2 MeSH |
650 | _ | 2 | |a Aged, 80 and over |2 MeSH |
650 | _ | 2 | |a Amnesia, Transient Global: blood |2 MeSH |
650 | _ | 2 | |a Amnesia, Transient Global: complications |2 MeSH |
650 | _ | 2 | |a Case-Control Studies |2 MeSH |
650 | _ | 2 | |a Female |2 MeSH |
650 | _ | 2 | |a Heart Diseases: blood |2 MeSH |
650 | _ | 2 | |a Heart Diseases: complications |2 MeSH |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Ischemic Attack, Transient: blood |2 MeSH |
650 | _ | 2 | |a Ischemic Attack, Transient: complications |2 MeSH |
650 | _ | 2 | |a Male |2 MeSH |
650 | _ | 2 | |a Middle Aged |2 MeSH |
650 | _ | 2 | |a Migraine Disorders: blood |2 MeSH |
650 | _ | 2 | |a Migraine Disorders: complications |2 MeSH |
650 | _ | 2 | |a Risk Factors |2 MeSH |
650 | _ | 2 | |a Troponin T: blood |2 MeSH |
700 | 1 | _ | |a Siegerink, B. |b 1 |
700 | 1 | _ | |a Ganeshan, R. |b 2 |
700 | 1 | _ | |a Audebert, H. J. |b 3 |
700 | 1 | _ | |a Endres, M. |0 P:(DE-2719)2811033 |b 4 |u dzne |
700 | 1 | _ | |a Nolte, C. H. |0 P:(DE-2719)9000234 |b 5 |u dzne |
700 | 1 | _ | |a Scheitz, J. F. |b 6 |
773 | 1 | 8 | |a 10.1111/ene.13920 |b : Wiley, 2019-02-21 |n 7 |p 986-991 |3 journal-article |2 Crossref |t European Journal of Neurology |v 26 |y 2019 |x 1351-5101 |
773 | _ | _ | |a 10.1111/ene.13920 |g Vol. 26, no. 7, p. 986 - 991 |0 PERI:(DE-600)2020241-6 |n 7 |q 26:7<986 - 991 |p 986-991 |t European journal of neurology |v 26 |y 2019 |x 1351-5101 |
909 | C | O | |o oai:pub.dzne.de:140772 |p VDB |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2811033 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)9000234 |
913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF3-890 |0 G:(DE-HGF)POF3-899H |2 G:(DE-HGF)POF3-800 |v Addenda |x 0 |
914 | 1 | _ | |y 2019 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J NEUROL : 2021 |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-11 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-11 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR J NEUROL : 2021 |d 2022-11-11 |
920 | 1 | _ | |0 I:(DE-2719)1811005 |k AG Endres |l Coordinator of Clinical Research |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1811005 |
980 | _ | _ | |a UNRESTRICTED |
999 | C | 5 | |a 10.1016/j.jacc.2018.08.1038 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.jacc.2018.08.1038 |
999 | C | 5 | |a 10.1161/STROKEAHA.114.007858 |9 -- missing cx lookup -- |2 Crossref |o 10.1161/STROKEAHA.114.007858 |
999 | C | 5 | |a 10.1136/heartjnl-2014-307306 |9 -- missing cx lookup -- |2 Crossref |o 10.1136/heartjnl-2014-307306 |
999 | C | 5 | |a 10.1016/S1474-4422(18)30336-3 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1474-4422(18)30336-3 |
999 | C | 5 | |y 1985 |2 Crossref |t Handbook of Clinical Neurology |o Caplan Handbook of Clinical Neurology 1985 |
999 | C | 5 | |a 10.1093/brain/113.3.639 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/113.3.639 |
999 | C | 5 | |a 10.1136/jnnp.53.10.834 |9 -- missing cx lookup -- |2 Crossref |o 10.1136/jnnp.53.10.834 |
999 | C | 5 | |a 10.1007/s00392-013-0590-1 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00392-013-0590-1 |
999 | C | 5 | |a 10.1177/2048872613519965 |9 -- missing cx lookup -- |2 Crossref |o 10.1177/2048872613519965 |
999 | C | 5 | |a 10.1016/j.ijcard.2015.06.117 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.ijcard.2015.06.117 |
999 | C | 5 | |a 10.1055/s-0033-1354598 |9 -- missing cx lookup -- |2 Crossref |o 10.1055/s-0033-1354598 |
999 | C | 5 | |a 10.1161/STR.0b013e318296aeca |9 -- missing cx lookup -- |2 Crossref |o 10.1161/STR.0b013e318296aeca |
999 | C | 5 | |a 10.1001/jama.2013.5809 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/jama.2013.5809 |
999 | C | 5 | |a 10.1016/S1474-4422(09)70344-8 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1474-4422(09)70344-8 |
999 | C | 5 | |a 10.1001/jama.2010.1708 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/jama.2010.1708 |
999 | C | 5 | |a 10.1161/CIRCULATIONAHA.110.005264 |9 -- missing cx lookup -- |2 Crossref |o 10.1161/CIRCULATIONAHA.110.005264 |
999 | C | 5 | |a 10.1016/j.ijcard.2014.10.036 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.ijcard.2014.10.036 |
999 | C | 5 | |a 10.1002/ana.24906 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.24906 |
999 | C | 5 | |a 10.1002/ana.24935 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.24935 |
999 | C | 5 | |a 10.1007/978-3-319-54476-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/978-3-319-54476-2 |
999 | C | 5 | |a 10.1016/S0140-6736(98)01442-1 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0140-6736(98)01442-1 |
999 | C | 5 | |y 2014 |2 Crossref |o Dohring 2014 |
999 | C | 5 | |a 10.1111/j.1468-1331.2007.01846.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1468-1331.2007.01846.x |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|